Pfizer New Pill Could Slow Down COVID Deaths & Hospitalizations At A Great Rate
Written by DJ Sight on November 8, 2021
Pfizer said it has an experimental antivirus that could prevent hospitalizations and deaths by 90%.
The FDA is currently reviewing the Pfizer antiviral pill and is showing a strong future with the pill. The United Kingdom is the first country that has already approved it.
Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to approve it.
https://www.cbsnews.com/news/covid-antiviral-pill-pfizer-cut-hospital-death-risk-by-89-percent/
